Display options
Cite
Homans DC, Sublett E, Dai XZ, et al. Effect of nifedipine on the myocardial and vascular response to myocardial ischemia. Basic Res Cardiol. 1986;81(4):394-406doi: 10.1007/BF01907460.
Homans, D. C., Sublett, E., Dai, X. Z., & Bache, R. J. (1986). Effect of nifedipine on the myocardial and vascular response to myocardial ischemia. Basic research in cardiology, 81(4), 394-406. https://doi.org/10.1007/BF01907460
Homans, D C, et al. "Effect of nifedipine on the myocardial and vascular response to myocardial ischemia." Basic research in cardiology vol. 81,4 (1986): 394-406. doi: https://doi.org/10.1007/BF01907460
Homans DC, Sublett E, Dai XZ, Bache RJ. Effect of nifedipine on the myocardial and vascular response to myocardial ischemia. Basic Res Cardiol. 1986 Jul-Aug;81(4):394-406. doi: 10.1007/BF01907460. PMID: 3778419.
Copy Download .nbib Format: NLM
Share it on

Basic Res Cardiol. 1986 Jul-Aug;81(4):394-406. doi: 10.1007/BF01907460.

Effect of nifedipine on the myocardial and vascular response to myocardial ischemia.

Basic research in cardiology

D C Homans, E Sublett, X Z Dai, R J Bache

PMID: 3778419 DOI: 10.1007/BF01907460

Abstract

Nifedipine reduces reactive hyperemia following brief coronary artery occlusions. To determine whether this is related to improvement in collateral blood flow to ischemic myocardium or alterations in myocardial oxygen consumption, ten chloralose anesthetized dogs were instrumented with coronary sinus catheters, circumflex artery flowmeters, and ultrasonic microcrystals for measurement of myocardial segment shortening. Myocardial oxygen consumption and circumflex coronary artery flow were determined at rest and during incremental infusions of isoproterenol. Myocardial blood flow measured with microspheres and segmental function were assessed during and following 30- and 60-second coronary artery occlusions. Thirty minutes after the intravenous administration of nifedipine, 10 micrograms/kg iv, all measurements were repeated. Nifedipine did not alter myocardial oxygen consumption or the relationship between oxygen consumption and circumflex coronary artery flow either at rest or during isoproterenol infusion. Following 60-second coronary occlusions, nifedipine reduced peak circumflex coronary artery flow (176 +/- 99 vs. 128 +/- 68 cc/min) and reactive hyperemia debt repayment (221 +/- 84 vs. 158 +/- 66%; p less than 0.01). Nifedipine did not alter flow to ischemic segments during coronary artery occlusions (0.16 +/- 0.10 vs. 0.19 +/- 0.13 ml/min/g mean transmural flow). Furthermore, nifedipine did not affect the severity of ischemic segment dysfunction, nor the rate of recovery of ischemic segment function following release of coronary artery occlusion. We conclude that the reduction in reactive hyperemia induced by nifedipine was not related to alterations in the severity of hypoperfusion in ischemic areas, or alterations in myocardial oxygen consumption. Reductions in reactive hyperemia produced by nifedipine did not impair recovery of mechanical function in postischemic myocardium.

References

  1. Circ Res. 1974 Dec;35(6):896-908 - PubMed
  2. Am Heart J. 1981 Sep;102(3 Pt 1):341-50 - PubMed
  3. Br Heart J. 1983 May;49(5):427-41 - PubMed
  4. J Pharmacol Exp Ther. 1982 Aug;222(2):494-500 - PubMed
  5. Circ Res. 1978 Sep;43(3):372-80 - PubMed
  6. Am J Cardiol. 1983 Mar 1;51(5):712-7 - PubMed
  7. Circ Res. 1981 Jun;48(6 Pt 1):937-42 - PubMed
  8. Cardiovasc Res. 1973 Jan;7(1):90-4 - PubMed
  9. Circ Res. 1978 Jul;43(1):83-92 - PubMed
  10. Circulation. 1984 May;69(5):1048-57 - PubMed
  11. Am J Physiol. 1965 Feb;208:231-6 - PubMed
  12. Circulation. 1984 Jan;69(1):131-41 - PubMed
  13. Eur J Pharmacol. 1980 May 2;63(2-3):209-12 - PubMed
  14. Eur J Pharmacol. 1982 Jul 30;81(4):543-50 - PubMed
  15. Am J Physiol. 1978 Jul;235(1):H87-94 - PubMed
  16. Cardiovasc Res. 1984 Apr;18(4):249-56 - PubMed
  17. Circulation. 1982 Jan;65(1):49-53 - PubMed
  18. Circ Res. 1973 Nov;33(5):588-96 - PubMed
  19. Eur Heart J. 1983 May;4 Suppl C:101-8 - PubMed
  20. Eur Heart J. 1983 May;4 Suppl C:25-31 - PubMed
  21. Circ Res. 1979 Jan;44(1):16-23 - PubMed
  22. Am J Physiol. 1965 Feb;208:224-30 - PubMed
  23. J Am Coll Cardiol. 1983 Dec;2(6):1141-5 - PubMed
  24. Circ Res. 1969 Nov;25(5):581-96 - PubMed
  25. Circ Res. 1982 May;50(5):678-87 - PubMed
  26. Am J Cardiol. 1982 Aug;50(2):281-8 - PubMed
  27. J Cardiovasc Pharmacol. 1984 May-Jun;6(3):536-42 - PubMed
  28. J Pharmacol Exp Ther. 1984 Jan;228(1):28-32 - PubMed
  29. Circulation. 1981 Mar;63(3):584-91 - PubMed
  30. Circ Res. 1979 Jun;44(6):788-95 - PubMed
  31. Am J Physiol. 1983 Mar;244(3):H378-86 - PubMed
  32. Circulation. 1982 Sep;66(3):579-88 - PubMed
  33. Am J Physiol. 1980 Nov;239(5):H658-63 - PubMed
  34. Basic Res Cardiol. 1982 Jan-Feb;77(1):26-33 - PubMed
  35. Am J Cardiol. 1979 Oct 22;44(5):817-24 - PubMed
  36. Acta Med Scand. 1978;204(3):179-84 - PubMed
  37. Am J Physiol. 1981 May;240(5):H709-15 - PubMed
  38. Am J Cardiol. 1979 Oct 22;44(5):825-31 - PubMed
  39. J Pharmacol Exp Ther. 1981 Apr;217(1):20-5 - PubMed

Substances

MeSH terms

Publication Types

Grant support